Casi Pharmaceuticals Inc (CASI) Live Share Price, Invest From India

Casi Pharmaceuticals Inc Stock Performance

as on February 26, 2026 at 7:59 am IST

Day's Low
Day's High
$0.21
Day's Price Range
$0.37
$0.23
8.70%
Downside
60.87%
Upside
52 Week's Low
52 Week's High
$0.21
52-Week Price Range
$3.09
$0.23
9.78%
Downside
1243.48%
Upside

Casi Pharmaceuticals Inc share price movements today

Previous Close: $0.80
Open: $0.33
Volume: 3.8M
Day's Low - High: $0.21 - $0.37
52 Week Low - High: $0.21 - $3.09

Casi Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Casi Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Casi Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Casi Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Casi Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Casi Pharmaceuticals Inc	BUY	$-	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.7B	114.3%	74.55	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$110.3B	110.12%	25.77	35.51%	NA
BeiGene, Ltd.	NA	$32.2B	NA	70.35	8.94%	NA
Regeneron Pharmaceuticals Inc	BUY	$67.0B	28.51%	15.6	29.65%	0.5599999999999999%

Analyst Recommendation on Casi Pharmaceuticals Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Casi Pharmaceuticals Inc. Average target price of $4

Casi Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Casi Pharmaceuticals Inc.

What analysts predicted

94.25%UPSIDE

Target Price

Current Price

$0.23

Analyzed by

7 Analysts

Target

$4.00

Casi Pharmaceuticals Inc target price $4, a slight upside of 94.25% compared to current price of $0.23. According to 7 analysts rating.

Casi Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	9	8	6	3	3	7	13	6	4	3
Gross Profit	5	5	4	1	2	4	3	3	2	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-10	-4	-6	-9	-6	-8	-14	-10	-13	-10
Net Profit Margin	-104.27%	-52.44%	-88.09%	-279.50%	-175.04%	-107.72%	-107.59%	-172.28%	-320.36%	-353.92%

Casi Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	4	15	30	43	33	28
Gross Profit	0	0	0	-1	0	5	17	27	20	11
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-7	-9	-10	-27	-45	-48	-36	-41	-26	-39
Net Profit Margin	-15104.01%	0.00%	0.00%	0.00%	-1098.09%	-318.92%	-121.50%	-95.14%	-79.51%	-137.57%

Global Institutional Holdings in Casi Pharmaceuticals Inc

Funds	Holdings
Citadel Advisors Llc	0.23%
Foresite Capital Management VI LLC	5.08%
Wellington Shields Capital Mgmt LLC	0.59%
Geode Capital Management, LLC	0.12%
TWO SIGMA SECURITIES, LLC	0.07%

See all

Insights on Casi Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -13.37M → -10.88M (in $), with an average increase of 22.9% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 72.3% return, outperforming this stock by 161.3%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 38.1% return, outperforming this stock by 129.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 13.35M → 3.07M (in $), with an average decrease of 37.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, CASI stock has moved down by -72.9%

About Casi Pharmaceuticals Inc

CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.

Organisation	Casi Pharmaceuticals Inc
E-voting on shares	Click here to vote

FAQs

What is Casi Pharmaceuticals Inc share price today?

Casi Pharmaceuticals Inc share price today is $0.23 as on February 26, 2026 at 2:29 am IST at the close of the market. Casi Pharmaceuticals Inc share today touched a day high of $0.37 and a low of $0.21.

What is the 52 week high and 52 week low for Casi Pharmaceuticals Inc share?

Casi Pharmaceuticals Inc share touched a 52 week high of $3.09 on August 15, 2025 and a 52 week low of $0.21 on February 25, 2026. Casi Pharmaceuticals Inc stock price today i.e. February 26, 2026 at 2:29 am IST is closed at $0.23,which is 92.56% down from its 52 week high and 10.84% up from its 52 week low.

How to invest in Casi Pharmaceuticals Inc Stock (CASI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Casi Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Casi Pharmaceuticals Inc Shares that will get you 6.5217 shares as per Casi Pharmaceuticals Inc share price of $0.23 per share as on February 26, 2026 at 2:29 am IST.

What is the minimum amount required to buy Casi Pharmaceuticals Inc Stock (CASI) from India?

Indian investors can start investing in Casi Pharmaceuticals Inc (CASI) shares with as little as ₹95.22 or $1 (as of May 26, 2026 at 3:35 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.20 in Casi Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on May 26, 2026 at 3:35 pm IST). Based on Casi Pharmaceuticals Inc share’s latest price of $0.23 as on February 26, 2026 at 2:29 am IST, you will get 43.4783 shares of Casi Pharmaceuticals Inc. Learn more about fractional shares .